U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H25FN2O2
Molecular Weight 416.4873
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KM-001

SMILES

OCC1=CC(=CC=C1[C@H]2CCN(C2)C(=O)C3=CC=C(F)C=N3)C4=CC=CC=C4C5CC5

InChI

InChIKey=NSHGEYJEPAJENJ-IBGZPJMESA-N
InChI=1S/C26H25FN2O2/c27-21-8-10-25(28-14-21)26(31)29-12-11-19(15-29)22-9-7-18(13-20(22)16-30)24-4-2-1-3-23(24)17-5-6-17/h1-4,7-10,13-14,17,19,30H,5-6,11-12,15-16H2/t19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C26H25FN2O2
Molecular Weight 416.4873
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 19:47:40 GMT 2025
Edited
by admin
on Wed Apr 02 19:47:40 GMT 2025
Record UNII
D5834H4GSQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(R)-(3-(2'-cyclopropyl-3-(hydroxymethyl)-[1,1'-biphenyl]-4-yl) pyrrolidin-1-yl)(5-fluoropyridin-2-yl)methanone
Preferred Name English
KM-001
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 1018524
Created by admin on Wed Apr 02 19:47:40 GMT 2025 , Edited by admin on Wed Apr 02 19:47:40 GMT 2025
Code System Code Type Description
CAS
2682864-35-1
Created by admin on Wed Apr 02 19:47:40 GMT 2025 , Edited by admin on Wed Apr 02 19:47:40 GMT 2025
PRIMARY
FDA UNII
D5834H4GSQ
Created by admin on Wed Apr 02 19:47:40 GMT 2025 , Edited by admin on Wed Apr 02 19:47:40 GMT 2025
PRIMARY
PUBCHEM
156814747
Created by admin on Wed Apr 02 19:47:40 GMT 2025 , Edited by admin on Wed Apr 02 19:47:40 GMT 2025
PRIMARY
SMS_ID
300000039878
Created by admin on Wed Apr 02 19:47:40 GMT 2025 , Edited by admin on Wed Apr 02 19:47:40 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
under development for the treatment of itch associated with moderate to severe pruritus in patients with lichen simplex chronicus (LSC), type I punctate palmoplantar keratoderma or pachyonychia congenital, severe palmoplantar keratoderma (Olmsted) and ichthyoses (Harlequin ichthyosis).